Idorsia

The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.

Business Model:

Revenue: $50.7M

Employees: 1,001-5,000

Rankings

Detailed Idorsia Information

Geographic Data

Idorsia headquarters map

Address: Hegenheimermattweg 91

City: Allschwil

State: basel-country

Zip: 4123

Country: CH

Financial Info

Stage:

Raised Last:

$583M

Raised Total:

$1B

Metrics

1,645,491Website Global Rank

17,256Website Monthly Traffic

Twitter Followers

Description

The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.

Contact Phone:

Contact Email:

Idorsia went public on 6/16/2017 on the SIX

Listed Exchange:
SIX

IPO Date:
6/16/2017

Ticker Symbol:
IDIA

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
9/2021 Santhera Pharmaceuticals Post-IPO Equity 0
1/2023 Santhera Pharmaceuticals Post-IPO Equity 5.4M
9/2021 Santhera Pharmaceuticals Post-IPO Equity 0
Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research